Evidence map›Paper›PMID 31101033›Full record

Observational studyBMC musculoskeletal disorders2019

Minimal clinically important decline in physical function over one year: EPOSA study.

Paola Siviero, Federica Limongi, Antonella Gesmundo, Sabina Zambon, Cyrus Cooper, Elaine M Dennison, Mark H Edwards, Erik J Timmermans, Suzan van der Pas, Laura A Schaap and 11 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC musculoskeletal disorders, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 3 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 3 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 7 institutions in 6 countries.

Paola SivieroNational Research Council, Neuroscience Institute - Aging Branch, Via Giustiniani 2, ,35128, Padova, Italy. paola.siviero@in.cnr.it.ORCID http://orcid.org/0000-0001-6567-5808
Federica LimongiNational Research Council, Neuroscience Institute - Aging Branch, Via Giustiniani 2, ,35128, Padova, Italy.
Antonella GesmundoDepartment of Medicine, University of Padova, Via 8 Febbraio 2, 35122, Padova, Italy.
Sabina ZambonDepartment of Medicine, University of Padova, Via 8 Febbraio 2, 35122, Padova, Italy.
Cyrus CooperMRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Tremona Road, Southampton, SO16 6YD, UK.
Elaine M DennisonMRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Tremona Road, Southampton, SO16 6YD, UK.
Mark H EdwardsMRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Tremona Road, Southampton, SO16 6YD, UK.
Erik J TimmermansDepartment of Epidemiology and Biostatistics, Amsterdam UMC - location VU University medical center, Amsterdam Public Health research institute, Amsterdam, the Netherlands.
Suzan van der PasDepartment of Epidemiology and Biostatistics, Amsterdam UMC - location VU University medical center, Amsterdam Public Health research institute, Amsterdam, the Netherlands.
Laura A SchaapDepartment of Epidemiology and Biostatistics, Amsterdam UMC - location VU University medical center, Amsterdam Public Health research institute, Amsterdam, the Netherlands.
Natasja M van SchoorDepartment of Epidemiology and Biostatistics, Amsterdam UMC - location VU University medical center, Amsterdam Public Health research institute, Amsterdam, the Netherlands.
Michael D DenkingerBethesda Geriatric Clinic, University of Ulm, Zollernring 26, 89073, Ulm, Germany.
Florian HerbolsheimerInstitute of the History Philosophy and Ethics of Medicine, University of Ulm, Frauensteige 6, 89075, Ulm, Germany.
Richard PeterInstitute of the History Philosophy and Ethics of Medicine, University of Ulm, Frauensteige 6, 89075, Ulm, Germany.
Maria Victoria CastellDepartment of Preventive Medicine and Public Health, Unit of Primary Care and Family Medicine, Faculty of Medicine, Universidad Autonoma de Madrid, Arzobispo Morcillo 4, 28029, Madrid, Spain.
Ángel OteroDepartment of Preventive Medicine and Public Health, Unit of Primary Care and Family Medicine, Faculty of Medicine, Universidad Autonoma de Madrid, Arzobispo Morcillo 4, 28029, Madrid, Spain.
Rocio QueipoDepartment of Preventive Medicine and Public Health, Unit of Primary Care and Family Medicine, Faculty of Medicine, Universidad Autonoma de Madrid, Arzobispo Morcillo 4, 28029, Madrid, Spain.
Nancy L PedersenDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, P.O.Box 281, Nobels väg 12A, SE-171 77, Stockholm, Sweden.
Dorly J H DeegDepartment of Epidemiology and Biostatistics, Amsterdam UMC - location VU University medical center, Amsterdam Public Health research institute, Amsterdam, the Netherlands.
Stefania MaggiNational Research Council, Neuroscience Institute - Aging Branch, Via Giustiniani 2, ,35128, Padova, Italy.
EPOSA Research Group
Amsterdam UMC Location Vrije Universiteit Amsterdam · NLNeuroscience Institute · ITSouthampton General Hospital · GBUniversidad Autónoma de Madrid · ESUniversität Ulm · DEUniversity of Padua · ITKarolinska Institutet · SE

Funding

Medical Research Council G0400491Medical Research Council MC_U147585819Medical Research Council MC_U147585824Medical Research Council MC_U147585827Medical Research Council MC_UP_A620_1014Medical Research Council MC_UU_12011/1Versus Arthritis 19583
6 · The paper itself

Abstract

backgroundThe Australian/Canadian hand Osteoarthritis Index (AUSCAN) and the Western Ontario and McMaster Universities knee and hip Osteoarthritis Index (WOMAC) are the most commonly used clinical tools to manage and monitor osteoarthritis (OA). Few studies have as yet reported longitudinal changes in the AUSCAN index regarding the hand. While there are published data regarding WOMAC assessments of the hip and the knee, the two sites have always evaluated separately. The current study therefore sought to determine the minimal clinically important difference (MCID) in decline in the AUSCAN hand and WOMAC hip/knee physical function scores over 1 year using anchor-based and distribution-based methods.

methodsThe study analysed data collected by the European Project on Osteoarthritis, a prospective observational study investigating six adult cohorts with and without OA by evaluating changes in the AUSCAN and WOMAC physical function scores at baseline and 12-18 months later. Pain and stiffness scores, the performance-based grip strength and walking speed and health-related quality of life measures were used as the study's anchors. Receiver operating characteristic curves and distribution-based methods were used to estimate the MCID in the AUSCAN and WOMAC physical function scores; only the data of those participants who possessed paired (baseline and follow up-measures) AUSCAN and WOMAC scores were included in the analysis.

resultsOut of the 1866 participants who were evaluated, 1842 had paired AUSCAN scores and 1845 had paired WOMAC scores. The changes in the AUSCAN physical function score correlated significantly with those in the AUSCAN pain score (r = 0.31). Anchor- and distribution-based approaches converged identifying 4 as the MCID for decline in the AUSCAN hand physical function. Changes in the WOMAC hip/knee physical function score were significantly correlated with changes in both the WOMAC pain score (r = 0.47) and the WOMAC stiffness score (r = 0.35). The different approaches converged identifying two as the MCID for decline in the WOMAC hip/knee physical function.

conclusionsThe most reliable MCID estimates of decline over 1 year in the AUSCAN hand and WOMAC hip/knee physical function scores were 4 and 2 points, respectively.

Indexed as

Physical Functional PerformanceSeverity of Illness IndexAgedAged, 80 and overArthralgiaFemaleFollow-Up StudiesHand JointsHip JointHumansKnee JointMaleOsteoarthritisPain MeasurementProspective StudiesQuality of LifeAUSCANFunctional declineHandHip/kneeMCIDOsteoarthritisWOMAC

Identifiers

PMID31101033
PMCPMC6525447
OpenAlexW2944885772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.